This study aims at determining serum levels of tryptophan and other metabolites of the kynurenine pathway in children with attention deficit hyperactivity disorder (ADHD) compared to healthy controls. Such metabolites interact with glutamate receptors in the central nervous system, potentially modulating mechanisms that are pivotal in ADHD and thus potentially representing peripheral biomarkers of the disorder. We measured serum levels of tryptophan and some metabolites of the kynurenine pathway in 102 children with ADHD and 62 healthy controls by liquid chromatography-tandem mass spectrometry (LC-MS/MS). As compared to healthy controls, children with ADHD showed a reduction in serum levels of anthranilic acid (-60%), kynurenic acid (-11.2%), and xanthurenic acid (-12.5%). In contrast, serum levels of tryptophan (+11.0%) and kynurenine (+48.6%) were significantly enhanced, and levels of quinolinic acid were unchanged in children with ADHD. In a logistic regression model, the presence of ADHD was predicted by low anthranilic acid and high tryptophan levels. These findings support the involvement of the kynurenine pathway in the pathophysiology of ADHD and suggest that anthranilic acid and tryptophan levels should be investigated as potential peripheral biomarker for ADHD.

Changes in serum levels of kynurenine metabolites in paediatric patients affected by ADHD / Evangelisti, Melania; DE ROSSI, Pietro; Rabasco, Jole; Donfrancesco, Renato; Lionetto, Luana; Capi, Matilde; Sani, Gabriele; Simmaco, Maurizio; Nicoletti, Ferdinando; Villa, MARIA PIA. - In: EUROPEAN CHILD & ADOLESCENT PSYCHIATRY. - ISSN 1018-8827. - 26:12(2017), pp. 1433-1441. [10.1007/s00787-017-1002-2]

Changes in serum levels of kynurenine metabolites in paediatric patients affected by ADHD

EVANGELISTI, MELANIA;DE ROSSI, Pietro;RABASCO, JOLE;CAPI, MATILDE;SANI, Gabriele;SIMMACO, Maurizio;NICOLETTI, Ferdinando;VILLA, MARIA PIA
2017

Abstract

This study aims at determining serum levels of tryptophan and other metabolites of the kynurenine pathway in children with attention deficit hyperactivity disorder (ADHD) compared to healthy controls. Such metabolites interact with glutamate receptors in the central nervous system, potentially modulating mechanisms that are pivotal in ADHD and thus potentially representing peripheral biomarkers of the disorder. We measured serum levels of tryptophan and some metabolites of the kynurenine pathway in 102 children with ADHD and 62 healthy controls by liquid chromatography-tandem mass spectrometry (LC-MS/MS). As compared to healthy controls, children with ADHD showed a reduction in serum levels of anthranilic acid (-60%), kynurenic acid (-11.2%), and xanthurenic acid (-12.5%). In contrast, serum levels of tryptophan (+11.0%) and kynurenine (+48.6%) were significantly enhanced, and levels of quinolinic acid were unchanged in children with ADHD. In a logistic regression model, the presence of ADHD was predicted by low anthranilic acid and high tryptophan levels. These findings support the involvement of the kynurenine pathway in the pathophysiology of ADHD and suggest that anthranilic acid and tryptophan levels should be investigated as potential peripheral biomarker for ADHD.
2017
adhd; biomarker; children; kynurenines; neurobiology
01 Pubblicazione su rivista::01a Articolo in rivista
Changes in serum levels of kynurenine metabolites in paediatric patients affected by ADHD / Evangelisti, Melania; DE ROSSI, Pietro; Rabasco, Jole; Donfrancesco, Renato; Lionetto, Luana; Capi, Matilde; Sani, Gabriele; Simmaco, Maurizio; Nicoletti, Ferdinando; Villa, MARIA PIA. - In: EUROPEAN CHILD & ADOLESCENT PSYCHIATRY. - ISSN 1018-8827. - 26:12(2017), pp. 1433-1441. [10.1007/s00787-017-1002-2]
File allegati a questo prodotto
File Dimensione Formato  
Evangelisti_Changes_2017.pdf

solo utenti autorizzati

Tipologia: Documento in Post-print (versione successiva alla peer review e accettata per la pubblicazione)
Licenza: Tutti i diritti riservati (All rights reserved)
Dimensione 483.26 kB
Formato Adobe PDF
483.26 kB Adobe PDF   Contatta l'autore
Evangelisti_Changes_2017.pdf

solo gestori archivio

Tipologia: Versione editoriale (versione pubblicata con il layout dell'editore)
Licenza: Tutti i diritti riservati (All rights reserved)
Dimensione 436.36 kB
Formato Adobe PDF
436.36 kB Adobe PDF   Contatta l'autore

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11573/965323
Citazioni
  • ???jsp.display-item.citation.pmc??? 13
  • Scopus 29
  • ???jsp.display-item.citation.isi??? 28
social impact